Article digest · Oct 2 AM
AI & Rare and Intractable Diseases — what each story says
Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.
24 stories0 with summaries11 topics
🔎 Diagnosing rare disease2
- Headlines only (the publisher did not provide a description)
- BioMarin taps Profluent AI models for novel enzyme therapiesAllSci · 10/01 12:54 UTC
- What Does Anthropic’s Wet Lab Mean for Pharma?Technology Networks · 09/30 14:15 UTC
🧬 Genomics3
- Headlines only (the publisher did not provide a description)
- Tempus AI, Inc. (TEM) stock price, news, quote and historyYahoo Finance UK · 09/30 00:05 UTC
- Anthropic pours A$10M more into Australian science, lifting total to A$13MDealroom · 09/22 03:57 UTC
- Tempus AI Sees Pricing, Data Growth Fueling Long-Term ExpansionTradingView · 09/22 00:02 UTC
💊 Therapies in development2
- Headlines only (the publisher did not provide a description)
- Insilico Medicine to Present First-in-Human Data for AI-Designed Pan-TEAD Inhibitor ISM6331 at ESMO 2026Insilico Medicine · 09/22 07:00 UTC
- AI Is Reshaping Gene Transfer Technologies — $258.7 Billion in VC Signals a Structural Shift in Biotech InvestmentGlobeNewswire · 10/01 13:38 UTC
🧠 Neuromuscular1
- Headlines only (the publisher did not provide a description)
- Huntington Ingalls Industries (HII) Stock Could Be 44% Undervalued After AI Vessel Expansionfinance.yahoo.com · 09/18 07:00 UTC
🛡️ Immune and connective tissue1
- Headlines only (the publisher did not provide a description)
- AI-based analysis reveals 4 distinct patterns of organ involvement in AAVANCA Vasculitis News · 09/23 15:53 UTC
🎀 Breast cancer4
- Headlines only (the publisher did not provide a description)
- How AI can help make life-changing breast cancer diagnosescbsnews.com · 10/01 12:13 UTC
- Everlywell Brings Clairity’s FDA-Authorized AI Breast Cancer Risk Assessment to Women NationwideBusiness Wire · 10/01 10:00 UTC
- Eve Wellness Announces Expansion Bringing Direct-to-Consumer AI Breast Screening to Walnut Creekprnewswire.com · 10/01 12:31 UTC
- KMUH Research Team and MacroInsight Innovation Tech Develop Real-Time AI Edge System for Mammography Quality Control｜Institute for Biotechnology and Medicine Industry│IBMIGlobal Medical Procurement Network · 10/01 04:22 UTC
🫁 Lung cancer2
- Headlines only (the publisher did not provide a description)
- AI Models Extract Smoking History for Lung Cancer ScreeningEuropean Medical Journal · 10/01 15:57 UTC
- CellCarta, Imagene AI Broaden Ties on AI Biomarkers, Companion DiagnosticsUnite.AI · 10/01 13:46 UTC
🩸 Leukaemia and lymphoma1
- Headlines only (the publisher did not provide a description)
- AI Can Spot Leukemia Cells on Blood Smears, But One Blast Type Keeps Slipping ThroughBioengineer.org · 10/01 13:12 UTC
🩺 Colorectal and GI1
- Headlines only (the publisher did not provide a description)
- Early Mayo Clinic AI Model Flagged Pancreatic Cancer Risk Up to Three Years Before Diagnosis in Health RecordsMedical Daily · 10/01 14:00 UTC
🖥️ Diagnosis and pathology4
- Headlines only (the publisher did not provide a description)
- CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Developmentprnewswire.com · 10/01 13:15 UTC
- Lunit to Present Five AI Biomarker Studies at ESMO 2026Seoul Economic Daily · 10/01 00:44 UTC
- AI In Radiology Market is Going to Booming Growth 2026-2033openPR.com · 10/01 09:37 UTC
- AI-Powered Imaging Diagnostics Market Size to Reach US$ 14.92openPR.com · 09/30 09:16 UTC
💊 Treatment and drug discovery3
- Headlines only (the publisher did not provide a description)
- AI moves beyond the note and into clinical workflowsHealthcare IT News · 10/01 16:42 UTC
- Talus Bio Launches Ptarmigan-1, the First Structure-Free AI Model for Proteome-Wide Drug DiscoveryBioSpace · 10/01 13:59 UTC
- Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug DevelopmentThe Manila Times · 10/01 09:37 UTC
The analysis and visual summary are in the Oct 2 AM issue. Japanese version here.